Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia
暂无分享,去创建一个
T. Shinkai | O. Ohmori | J. Nakamura | H. Hori | T Shinkai | O Ohmori | H Hori | J Nakamura
[1] Ivan Izquierdo,et al. Retrograde messengers, long-term potentiation and memory , 1995, Brain Research Reviews.
[2] J. Drazen,et al. Neuronal NO synthase (NOS1) is a major candidate gene for asthma. , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[3] E. Garcia-Rill,et al. The brain stem reticular formation in schizophrenia , 1991, Psychiatry Research: Neuroimaging.
[4] T. Dawson,et al. Nitric oxide in health and disease of the nervous system , 1997, Molecular Psychiatry.
[5] P. Emson,et al. Localization of brain nitric oxide synthase (NOS) to human chromosome 12. , 1992, Genomics.
[6] S. Snyder,et al. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Garthwaite,et al. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. , 1989, European journal of pharmacology.
[8] S. Mukherjee,et al. Free radical pathology and antioxidant defense in schizophrenia: a review , 1996, Schizophrenia Research.
[9] T. Dawson,et al. Neurobiology of nitric oxide. , 1996, Critical reviews in neurobiology.
[10] S. Vincent,et al. Nitric oxide: A radical neurotransmitter in the central nervous system , 1994, Progress in Neurobiology.
[11] F. Murad,et al. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Kammen,et al. Effects of haloperidol on antioxidant defense system enzymes in schizophrenia. , 1998, Journal of psychiatric research.
[13] Jeffrey K. Yao,et al. Reduced level of plasma antioxidant uric acid in schizophrenia , 1998, Psychiatry Research.
[14] S H Snyder,et al. Nitric oxide: first in a new class of neurotransmitters. , 1992, Science.
[15] P. Marsden,et al. Structural organization of the human neuronal nitric oxide synthase gene (NOS1). , 1994, The Journal of biological chemistry.
[16] D. Horrobin,et al. Fatty acid levels in the brains of schizophrenics and normal controls , 1991, Biological Psychiatry.
[17] E. Kandel,et al. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[18] S. Mahadik,et al. Oxidative injury and potential use of antioxidants in schizophrenia. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.
[19] J. Garthwaite. Glutamate, nitric oxide and cell-cell signalling in the nervous system , 1991, Trends in Neurosciences.
[20] T. L. Krukoff. Central actions of nitric oxide in regulation of autonomic functions , 1999, Brain Research Reviews.
[21] Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase , 1991 .
[22] S. Vincent,et al. Neuronal NADPH diaphorase is a nitric oxide synthase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Cadet,et al. Free radical mechanisms in schizophrenia and tardive dyskinesia , 1994, Neuroscience & Biobehavioral Reviews.
[24] J. Gilbert,et al. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. , 2000, American journal of human genetics.
[25] J. Smythies. Redox aspects of signaling by catecholamines and their metabolites. , 2000, Antioxidants & redox signaling.
[26] R. Pioli,et al. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6 , 1998, Schizophrenia Research.
[27] Terry D. Lee,et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. , 1992, Science.
[28] R. Reddy,et al. Free radical pathology in schizophrenia: a review. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.
[29] S. Mukherjee,et al. Impaired antioxidant defense at the onset of psychosis , 1996, Schizophrenia Research.
[30] J. Cunningham,et al. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. , 1992, The Journal of biological chemistry.
[31] Yang Wang,et al. Neuronal NOS: gene structure, mRNA diversity, and functional relevance. , 1999, Critical reviews in neurobiology.
[32] S. Snyder,et al. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Smythies. Oxidative reactions and schizophrenia: A review-discussion , 1997, Schizophrenia Research.
[34] C A Sandman,et al. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. , 1993, Archives of general psychiatry.
[35] J J Kim,et al. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. , 1993, Archives of general psychiatry.
[36] S. Mukherjee,et al. Enzymes of the antioxidant defense system in chronic schizophrenic patients , 1991, Biological Psychiatry.
[37] T. Shinkai,et al. Manganese Superoxide Dismutase Gene Polymorphism and Schizophrenia: Relation to Tardive Dyskinesia , 2000, Neuropsychopharmacology.
[38] E. Garcia-Rill,et al. Mesopontine neurons in schizophrenia , 1995, Neuroscience.
[39] S. Dursun,et al. Lack of phencyclidine-induced effects in mice with reduced neuronal nitric oxide synthase , 2001, Psychopharmacology.